Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Drug Metab Dispos ; 38(12): 2239-45, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20810540

ABSTRACT

The flavin-containing monooxygenase (FMO) family of enzymes oxygenates nucleophilic xenobiotics and endogenous substances. Human FMO3 and FMO5 are the predominant FMO forms in adult liver. These enzymes are naturally membrane-bound, and recombinant proteins are commercially available as microsomal preparations from insect cells (i.e., Supersome FMO). As an alternative, FMO3 has previously been expressed as a soluble protein, through use of an N-terminal maltose-binding protein (MBP) fusion. In the current study, MBP fusions of both human FMO3 and FMO5 were prepared to >90% purity in the presence of detergent and characterized for biochemical and kinetic parameters, and the parameters were compared with those of Supersome FMO samples. Although MBP-FMO enzymes afforded lower rates of turnover than the corresponding Supersome FMOs, both types of FMO showed identical substrate dependencies and similar responses to changes in assay conditions. Of interest, the FMO3 enzymes showed a 2-fold activation of k(cat)/K(m) in the presence of Triton X-100. Oligomeric analysis of MBP-FMO3 also showed disassociation from a high-order oligomeric form to a monomeric status in the presence of Triton X-100. This report serves as the first direct comparison between Supersome FMOs and the corresponding MBP fusions and the first report of a detergent-based activation of k(cat)/K(m) that corresponds to changes in oligomerization.


Subject(s)
Maltose-Binding Proteins/genetics , Oxygenases/genetics , Recombinant Fusion Proteins/biosynthesis , Humans , Kinetics , Maltose-Binding Proteins/biosynthesis , Maltose-Binding Proteins/chemistry , Oxygenases/biosynthesis , Oxygenases/chemistry , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/isolation & purification
2.
J Bacteriol ; 191(22): 6936-49, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19767425

ABSTRACT

GTP cyclohydrolase I (GCYH-I) is an essential Zn(2+)-dependent enzyme that catalyzes the first step of the de novo folate biosynthetic pathway in bacteria and plants, the 7-deazapurine biosynthetic pathway in Bacteria and Archaea, and the biopterin pathway in mammals. We recently reported the discovery of a new prokaryotic-specific GCYH-I (GCYH-IB) that displays no sequence identity to the canonical enzyme and is present in approximately 25% of bacteria, the majority of which lack the canonical GCYH-I (renamed GCYH-IA). Genomic and genetic analyses indicate that in those organisms possessing both enzymes, e.g., Bacillus subtilis, GCYH-IA and -IB are functionally redundant, but differentially expressed. Whereas GCYH-IA is constitutively expressed, GCYH-IB is expressed only under Zn(2+)-limiting conditions. These observations are consistent with the hypothesis that GCYH-IB functions to allow folate biosynthesis during Zn(2+) starvation. Here, we present biochemical and structural data showing that bacterial GCYH-IB, like GCYH-IA, belongs to the tunneling-fold (T-fold) superfamily. However, the GCYH-IA and -IB enzymes exhibit significant differences in global structure and active-site architecture. While GCYH-IA is a unimodular, homodecameric, Zn(2+)-dependent enzyme, GCYH-IB is a bimodular, homotetrameric enzyme activated by a variety of divalent cations. The structure of GCYH-IB and the broad metal dependence exhibited by this enzyme further underscore the mechanistic plasticity that is emerging for the T-fold superfamily. Notably, while humans possess the canonical GCYH-IA enzyme, many clinically important human pathogens possess only the GCYH-IB enzyme, suggesting that this enzyme is a potential new molecular target for antibacterial development.


Subject(s)
Bacterial Proteins/chemistry , Bacterial Proteins/metabolism , Folic Acid/biosynthesis , GTP Cyclohydrolase/chemistry , GTP Cyclohydrolase/metabolism , Zinc/metabolism , Amino Acid Sequence , Bacillus subtilis/genetics , Bacillus subtilis/metabolism , Bacterial Proteins/genetics , Binding Sites , Chromatography, Gel , Chromatography, High Pressure Liquid , Computational Biology , Crystallography, X-Ray , GTP Cyclohydrolase/genetics , Manganese/metabolism , Models, Molecular , Molecular Sequence Data , Neisseria gonorrhoeae/genetics , Neisseria gonorrhoeae/metabolism , Protein Binding , Protein Structure, Secondary , Sequence Homology, Amino Acid
3.
Nucleic Acids Res ; 37(9): 2894-909, 2009 May.
Article in English | MEDLINE | ID: mdl-19287007

ABSTRACT

Threonylcarbamoyladenosine (t(6)A) is a universal modification found at position 37 of ANN decoding tRNAs, which imparts a unique structure to the anticodon loop enhancing its binding to ribosomes in vitro. Using a combination of bioinformatic, genetic, structural and biochemical approaches, the universal protein family YrdC/Sua5 (COG0009) was shown to be involved in the biosynthesis of this hypermodified base. Contradictory reports on the essentiality of both the yrdC wild-type gene of Escherichia coli and the SUA5 wild-type gene of Saccharomyces cerevisiae led us to reconstruct null alleles for both genes and prove that yrdC is essential in E. coli, whereas SUA5 is dispensable in yeast but results in severe growth phenotypes. Structural and biochemical analyses revealed that the E. coli YrdC protein binds ATP and preferentially binds RNA(Thr) lacking only the t(6)A modification. This work lays the foundation for elucidating the function of a protein family found in every sequenced genome to date and understanding the role of t(6)A in vivo.


Subject(s)
Adenosine/analogs & derivatives , DNA-Binding Proteins/genetics , Escherichia coli Proteins/genetics , RNA, Transfer/chemistry , RNA-Binding Proteins/genetics , Saccharomyces cerevisiae Proteins/genetics , Adenosine/biosynthesis , Adenosine Triphosphate/metabolism , Amino Acid Sequence , Escherichia coli Proteins/chemistry , Escherichia coli Proteins/metabolism , Genes, Essential , Genomics , Molecular Sequence Data , RNA, Transfer/metabolism , RNA, Transfer, Thr/chemistry , RNA, Transfer, Thr/metabolism , RNA-Binding Proteins/chemistry , RNA-Binding Proteins/metabolism
4.
Article in English | MEDLINE | ID: mdl-16511203

ABSTRACT

QueF (MW = 19.4 kDa) is a recently characterized nitrile oxidoreductase which catalyzes the NADPH-dependent reduction of 7-cyano-7-deazaguanine (preQ0) to 7-aminomethyl-7-deazaguanine, a late step in the biosynthesis of the modified tRNA nucleoside queuosine. Initial crystals of homododecameric Bacillus subtilis QueF diffracted poorly to 8.0 A. A three-dimensional model based on homology with the tunnel-fold enzyme GTP cyclohydrolase I suggested catalysis at intersubunit interfaces and a potential role for substrate binding in quaternary structure stabilization. Guided by this insight, a second crystal form was grown that was strictly dependent on the presence of preQ0. This crystal form diffracted to 2.25 A resolution.


Subject(s)
Bacillus subtilis/enzymology , Crystallography, X-Ray/methods , Nucleoside Q/chemistry , Oxidoreductases/chemistry , Bacillus subtilis/metabolism , Catalysis , Computational Biology , Crystallization , GTP Cyclohydrolase/chemistry , Guanine/analogs & derivatives , Guanine/chemistry , Models, Chemical , Models, Molecular , NADP/chemistry , Protein Conformation , Protein Isoforms , Protein Structure, Tertiary , Pyrimidinones/chemistry , Pyrroles/chemistry , RNA Processing, Post-Transcriptional , RNA, Transfer/chemistry , X-Ray Diffraction
SELECTION OF CITATIONS
SEARCH DETAIL
...